-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QGfLc23OZ4gpYNfYPLkymR1tUv1GE3068M5kgCXOKgt6ukFjB2pfop7Be7knH9jR eAMXznU/49Us1R+Ra0V25Q== 0000000000-09-007865.txt : 20090330 0000000000-09-007865.hdr.sgml : 20090330 20090213164931 ACCESSION NUMBER: 0000000000-09-007865 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090213 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@,3`W M-3,O3R`X+T4@-C0V-2].(#$O5"`Q,#4X-R]((%L@-3DV(#$V.%T^/@UE;F1O M8FH-("`@("`@("`@("`@("`@("`@("`@#0IX'1=+T5X=$=3=&%T93P\+T=3 M,2`Q.2`P(%(^/CX^#65N9&]B:@TQ,"`P(&]B:@T\/"]3=6)T>7!E+U1R=654 M>7!E+T9O;G1$97-C7!E+T9O;G0^/@UE M;F1O8FH-,3(@,"!O8FH-6R])0T-"87-E9"`Q-2`P(%)=#65N9&]B:@TQ,R`P M(&]B:@T\/"],96YG=&@@-S`T+T9I;'1E0 MK*WQE8X@U4!"RJ81;F@'.BTL"DEJ_K:6#4[RQX`%#1B%9_RY'IE.(9FURSC! M"`OW$\F'?QH02NG$A'+;T=;Z97^7'.8\U7+MQ"2T92Z`%TOX1A8$[KC,P?F= MW)C3@R3K^455OD!$&84S$?_S9RZ>U(:K'3!_!!ZET[-7<%P\VF`!7^5HJC@8<55$X6G M8E/)E.=ZY(08#[X4*3D`83T(J\7]6@A(RJU0<(500HV`!=4*YGE9JH[=H!;7 M7%=PJ3:%WLKT[PCNQ19NA-)B!S2.6=09*NH,9;P3[;WC[\UDQ4K)^0OL_JVDYZ9+>7JU>K0Z;V')V[1,>J=(6"U2?C,]X]/`#W)0'$[9K8P-](&Y@@Z^ M1:_S*TK(-@J-H$RJIFL\&UV&>!7:0VJH9#O9>JPM0GA.MI/:>>QXQCWG>'LA MBU0@H]WH&*<.\=ZMZK['D-;&MV]$EBELQ4-3.I1%J5]9M"*^VU';(ZEN`ZL=X$&`!21HM,"@T*96YD7!E+U1R=654>7!E+T9O;G1$97-C]W]IG M[W/WV7N?M2X`)$\?+B\%E@(@F2?@!WHXTU>%1]"Q_0`&>(`!I@`P6>FIOD'N MP4`D+S<7>KK("?R+W@P!2/R^9>CI3Z>#_T_2K%2^``#(7\3F;$XZ2\3Y(D[* M%*2*[3,BIL8DBAE&B9DO2E#$6\3BG%/9R6PQ]XAX M>X:0(V+$1\0%&5Q.IHAOBU@S29C,%?%;<6PRAYD.`(HDM@LXK'@1FXB8Q`\. M=!'Q<@!PI+@O..8+%G"R!.)#N:2D9O.YW(RDS@"@:$_ MDY7(Y+/I+BG)J4Q>-@"+9_XL&7%MZ:(B6YI:6UH:FAF9?E&H_[KX-R7N[2*] M"OC<,XC6]X?MK_Q2Z@!@S(IJL^L/6\Q^`#JV`B!W_P^;YB$`)$5]:[_QQ7EH MXGF)%PA2;8R-,S,SC;@?!?W[KG")^)'.C?LP`OB!8!`.U@(6B`?)@`\R02[8#`I`$=@%]H)*4`/J02-H`2=` M!S@-+H#+X#JX">Z`!V`$C(/G8`:\`?,0!&$A,D2!Y"%52`LR@,P@!F0/N4$^ M4"`4#D5#<1`/$D*YT!:H""J%*J%:J!'Z%CH%78"N0@/0/6@4FH)^A=[#"$R" MJ;`RK`T;PPS8"?:&@^$UT(%U(+W(+&4&FD7U"W4*&H&]0E-1BNA#=`V:"_T*G0<.A-=@"Y' M-Z#;T)?0=]#CZ#<8#(:&T<%883PQX9@$S#I,,>8`IA5S'C.`&:P! MU@[KAV5B!=@"['[L,>PY["!V'/L61\2IXLQP[K@('`^7ARO'->'.X@9Q$[AY MO!1>"V^#]\.S\=GX$GP]O@M_`S^.GR=($W0(=H1@0@)A,Z&"T$*X1'A(>$4D M$M6)UL0`(I>XB5A!/$Z\0APEOB/)D/1)+J1(DI"TDW2$=)YTC_2*3"9KDQW) M$60!>2>YD7R1_)C\5H(B823A)<&6V"A1)=$N,2CQ0A(OJ27I)+E6,D>R7/*D MY`W):2F\E+:4BQ13:H-4E=0IJ6&I66F*M*FTGW2R=+%TD_15Z4D9K(RVC)L, M6R9?YK#,19DQ"D+1H+A06)0ME'K*) M5X*5])4"E=8I'5;J4YI55E'V4$Y5WJ]\47E:A:;BJ)*@4J9R5F5*E:)JK\I5 M+5,]I_J,+DMWHB?1*^@]]!DU)35/-:%:K5J_VKRZCGJ(>IYZJ_HC#8(&0R-6 MHTRC6V-&4U735S-7LUGSOA9>BZ$5K[5/JU=K3EM'.TQ[FW:']J2.G(Z73HY. ML\Y#7;*N@VZ:;IWN;3V,'D,O4>^`WDU]6-]"/UZ_2O^&`6Q@:<`U.&`PL!2] MU'HI;VG=TF%#DJ&3889AL^&H$XT\F%B9))O4F M#TQE3%>8YIEVF?YJIF_&,JLRNVU.-G:?YRF<$RSK*#R^Y:4"Q\+;99 M=%M\M+2RY%NV6$Y9:5I%6U5;#3.H#']&,>.*-=K:V7JC]6GK=S:6-@*;$S:_ MV!K:)MHVV4XNUUG.65Z_?,Q.W8YI5VLW8D^WC[8_9#_BH.;`=*AS>.*HXY;PKXNKA6NC:[R;C%N)6Z?;87=T] MSKW9?<;#PF.=QWE/M*>WYV[/82]E+Y97H]?,"JL5ZU?T>).\@[PKO9_XZ/OP M?;I\8=\5OGM\'Z[46LE;V>$'_+S\]O@]\M?Q3_/_/@`3X!]0%?`TT#0P-[`W MB!(4%=04]";8.;@D^$&(;H@PI#M4,C0RM#%T+LPUK#1L9)7QJO6KKH%)64K)2! M5(/4@M21-)NTO6DS?&]^0SJ4OB:]4T`5_4SU"76%6X6C&?8951EO,T,S3V9) M9_&R^K+ULW=D3^2XYWR]#K6.M:X[5RUW<^[H>J?UM1N@#3$;NC=J;,S?.+[) M8]/1S83-B9M_R#/)*\U[O25L2U>^=N M[]]AOF/_CD^%[,)K129%Y44?BEG%U[XR_:KBJX6=L3O[2RQ+#N["[.+M&MKM ML/MHJ71I3NG8'M\][67TLL*RUWNC]EXM7U9>LX^P3[AOI,*GHG._YOY=^S]4 MQE?>J7*N:JU6JMY1/7>`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`#`/>$\_L*#0IE;F1S=')E M86T-96YD;V)J#3$V(#`@;V)J#3P\+U-T96U6(#$Q-BXX-C2A4:6UE7!E+U!A9V5S+TMI9'-;."`P(%)=/CX-96YD M;V)J#30@,"!O8FH-/#PO4W5B='EP92]834PO3&5N9W1H(#,V-#G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@] M(F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`T+C`M M8S,Q-B`T-"XR-3,Y,C$L(%-U;B!/8W0@,#$@,C`P-B`Q-SHQ-#HS.2(^"B`@ M(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&%P.D-R96%T M941A=&4^,C`P.2TP,BTQ,U0Q-CHS,SHQ-RTP-3HP,#PO>&%P.D-R96%T941A M=&4^"B`@("`@(#PO&%P34TZ26YS=&%N8V5)1#YU M=6ED.F9F-S)E.#-E+38R9&4M-#%F,BTY868U+3DU,V$V9F$S8V)E-#PO>&%P M34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO MF4@-CX^#0IS=&%R='AR968-"C$Q-@T*)25%3T8-"C\_ ` end -----END PRIVACY-ENHANCED MESSAGE-----